The following is a summary of “Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA ...

Inconsistent adherence to the guidelines led to delayed heart failure treatment optimization and underutilization of key ...

As society ages, the number of patients with heart failure is rapidly increasing. The progression of the disease is caused by excessive growth of fibrotic tissue in the heart, known as fibrosis. A ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal.   Cardiac rehabilitation (CR) typically consists of physical activity supplemented with lifestyle ...

Cardiac contractility modulation works daily to improve the contraction of the heart, making it stronger and relieving ...

Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...

A recent study found that tirzepatide, the active ingredient in Zepbound and Mounjaro, could reduce the risk of ...

A survey of cardiologists has found that patient lifestyle is the biggest challenge when treating patients seeking cardiology care.

The RESHAPE-HF2 trial aimed to settle the debate initiated by the conflicting COAPT and MITRA-FR trials, however, it did not clarify the role of transcatheter edge-to-edge repair in heart failure.

For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

Phoenix researcher was recently awarded a $1.9 million National Institutes of Health grant to study the molecular mechanisms of how dilated cardiomyopathy progresses to heart failure, which could ...